Elanco Animal Health Quarterly Income Statements Chart
Quarterly
|
Annual
Elanco Animal Health Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue | 1,241,000,000 | 1,193,000,000 | 1,020,000,000 | 1,030,000,000 | 1,184,000,000 | 1,205,000,000 | 1,035,000,000 | 1,068,000,000 | 1,057,000,000 | 1,257,000,000 | 981,000,000 | 1,028,000,000 | 1,177,000,000 | 1,225,000,000 | 1,113,000,000 | 1,131,000,000 | 1,279,000,000 | 1,242,000,000 | 1,139,700,000 | 889,600,000 | 586,300,000 | 657,700,000 | 571,000,000 | 771,300,000 | 781,600,000 | 731,100,000 | 761,100,000 |
| yoy | 4.81% | -1.00% | -1.45% | -3.56% | 12.02% | -4.14% | 5.50% | 3.89% | -10.20% | 2.61% | -11.86% | -9.11% | -7.97% | -1.37% | -2.34% | 27.14% | 118.15% | 88.84% | 99.60% | 15.34% | -24.99% | -10.04% | -24.98% | ||||
| qoq | 4.02% | 16.96% | -0.97% | -13.01% | -1.74% | 16.43% | -3.09% | 1.04% | -15.91% | 28.13% | -4.57% | -12.66% | -3.92% | 10.06% | -1.59% | -11.57% | 2.98% | 8.98% | 28.11% | 51.73% | -10.86% | 15.18% | -25.97% | -1.32% | 6.91% | -3.94% | |
| cost of sales | 528,000,000 | 509,000,000 | 501,000,000 | 492,000,000 | 495,000,000 | 515,000,000 | 516,000,000 | 487,000,000 | 434,000,000 | 494,000,000 | 448,000,000 | 472,000,000 | 484,000,000 | 509,000,000 | 512,000,000 | 502,000,000 | 551,000,000 | 569,000,000 | 596,200,000 | 441,800,000 | 295,900,000 | 332,700,000 | 265,050,000 | 360,400,000 | 356,000,000 | 343,800,000 | 369,800,000 |
| gross profit | 713,000,000 | 684,000,000 | |||||||||||||||||||||||||
| yoy | |||||||||||||||||||||||||||
| qoq | 4.24% | ||||||||||||||||||||||||||
| gross margin % | 57.45% | 57.33% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| research and development | 92,000,000 | 94,000,000 | 81,000,000 | 87,000,000 | 89,000,000 | 87,000,000 | 79,000,000 | 86,000,000 | 81,000,000 | 81,000,000 | 80,000,000 | 78,000,000 | 82,000,000 | 81,000,000 | 92,000,000 | 94,000,000 | 94,000,000 | 89,000,000 | 112,700,000 | 88,100,000 | 59,400,000 | 66,800,000 | 50,700,000 | 69,900,000 | 68,800,000 | 64,100,000 | 58,900,000 |
| marketing, selling and administrative | 400,000,000 | 341,000,000 | 300,000,000 | 323,000,000 | 354,000,000 | 337,000,000 | 292,000,000 | 313,000,000 | 353,000,000 | 327,000,000 | 304,000,000 | 298,000,000 | 343,000,000 | 320,000,000 | 329,000,000 | 342,000,000 | 385,000,000 | 348,000,000 | 374,100,000 | 277,700,000 | 162,800,000 | 182,000,000 | 143,575,000 | 192,300,000 | 200,900,000 | 181,100,000 | 179,000,000 |
| amortization of intangible assets | 136,000,000 | 128,000,000 | 130,000,000 | 133,000,000 | 131,000,000 | 133,000,000 | 138,000,000 | 140,000,000 | 136,000,000 | 134,000,000 | 130,000,000 | 128,000,000 | 133,000,000 | 137,000,000 | 139,000,000 | 141,000,000 | 129,000,000 | 147,000,000 | 163,700,000 | 95,600,000 | 49,000,000 | 51,600,000 | 37,250,000 | 50,700,000 | 49,300,000 | 49,000,000 | 48,700,000 |
| asset impairment, restructuring and other special charges | 1,000,000 | 9,000,000 | 7,000,000 | 17,000,000 | 80,000,000 | 46,000,000 | 36,000,000 | 16,000,000 | 35,000,000 | 40,000,000 | 25,000,000 | 26,000,000 | 86,000,000 | 46,000,000 | 110,000,000 | 111,000,000 | 299,000,000 | 108,000,000 | 167,300,000 | 262,200,000 | 119,400,000 | 74,800,000 | 33,475,000 | 77,200,000 | 31,800,000 | ||
| interest expense, net of capitalized interest | 48,000,000 | 40,000,000 | 46,000,000 | 58,000,000 | 65,000,000 | 66,000,000 | 67,000,000 | 72,000,000 | 74,000,000 | 64,000,000 | 62,000,000 | 60,000,000 | 67,000,000 | 52,000,000 | 55,000,000 | 60,000,000 | 60,000,000 | 61,000,000 | 60,400,000 | 48,100,000 | 24,800,000 | 16,500,000 | 15,050,000 | 18,700,000 | 20,700,000 | 20,800,000 | |
| other income | 11,000,000 | 12,000,000 | 6,000,000 | 1,000,000 | 2,000,000 | 9,000,000 | 34,000,000 | 9,000,000 | 23,000,000 | 9,000,000 | 15,000,000 | 8,000,000 | 9,000,000 | -3,000,000 | 11,000,000 | -3,000,000 | |||||||||||
| income before income taxes | 25,000,000 | 60,000,000 | -51,000,000 | 559,000,000 | -32,000,000 | 12,000,000 | -127,000,000 | -1,097,000,000 | -79,000,000 | 108,000,000 | -83,000,000 | -42,000,000 | -18,000,000 | 71,000,000 | -121,000,000 | -130,000,000 | -236,000,000 | -80,000,000 | -318,100,000 | -209,000,000 | -77,100,000 | -67,800,000 | 20,625,000 | -12,500,000 | 50,200,000 | 44,800,000 | 78,800,000 |
| income tax benefit | 14,000,000 | -7,000,000 | 48,250,000 | 195,000,000 | 18,000,000 | 18,000,000 | -28,000,000 | 7,000,000 | 4,000,000 | 23,000,000 | -24,000,000 | -26,000,000 | -26,000,000 | -19,000,000 | |||||||||||||
| net income | 11,000,000 | 67,000,000 | -8,000,000 | 364,000,000 | -50,000,000 | 32,000,000 | -141,000,000 | -1,096,000,000 | -97,000,000 | 103,000,000 | -55,000,000 | -49,000,000 | -22,000,000 | 48,000,000 | -97,000,000 | -104,000,000 | -210,000,000 | -61,000,000 | -322,800,000 | -135,000,000 | -53,200,000 | -49,100,000 | 19,350,000 | 10,000,000 | 35,900,000 | 31,500,000 | 60,200,000 |
| yoy | -122.00% | 109.38% | -94.33% | -133.21% | -48.45% | -68.93% | 156.36% | 2136.73% | 340.91% | 114.58% | -43.30% | -52.88% | -89.52% | -178.69% | -69.95% | -22.96% | 294.74% | 24.24% | -1768.22% | -1450.00% | -248.19% | -255.87% | -67.86% | ||||
| qoq | -83.58% | -937.50% | -102.20% | -828.00% | -256.25% | -122.70% | -87.14% | 1029.90% | -194.17% | -287.27% | 12.24% | 122.73% | -145.83% | -149.48% | -6.73% | -50.48% | 244.26% | -81.10% | 139.11% | 153.76% | 8.35% | -353.75% | 93.50% | -72.14% | 13.97% | -47.67% | |
| net income margin % | 0.89% | 5.62% | -0.78% | 35.34% | -4.22% | 2.66% | -13.62% | -102.62% | -9.18% | 8.19% | -5.61% | -4.77% | -1.87% | 3.92% | -8.72% | -9.20% | -16.42% | -4.91% | -28.32% | -15.18% | -9.07% | -7.47% | 3.39% | 1.30% | 4.59% | 4.31% | 7.91% |
| earnings per share: | |||||||||||||||||||||||||||
| basic | 0.02 | 0.14 | -0.02 | 0.74 | -0.1 | 0.06 | -0.2 | 0.21 | -0.04 | 0.1 | -0.71 | -0.29 | -0.13 | -0.12 | 0.053 | 0.03 | 0.1 | 0.09 | |||||||||
| diluted | 0.02 | 0.13 | -0.02 | 0.73 | -0.1 | 0.06 | -0.2 | 0.21 | -0.04 | 0.1 | -0.71 | -0.29 | -0.13 | -0.12 | 0.053 | 0.03 | 0.1 | 0.09 | |||||||||
| weighted-average shares outstanding: | |||||||||||||||||||||||||||
| basic | 496.6 | 495.1 | 494 | 494.3 | 494.2 | 493.2 | 492.3 | 492.7 | 492.6 | 491.1 | 488.3 | 488.4 | 488.4 | 488 | 487.2 | 487.3 | 487.3 | 486.7 | 441.4 | 462.4 | 413.2 | 403.9 | 371.6 | 365.7 | 365.7 | ||
| diluted | 500.1 | 499.1 | 497.3 | 497.7 | 494.2 | 496 | 492.3 | 492.7 | 492.6 | 492.8 | 488.3 | 488.4 | 488.4 | 492.2 | 487.2 | 487.3 | 487.3 | 486.7 | 441.4 | 462.4 | 413.2 | 403.9 | 373.2 | 367 | 366 | ||
| costs, expenses and other: | |||||||||||||||||||||||||||
| goodwill impairment | 1,042,000,000 | ||||||||||||||||||||||||||
| gain on divestiture | -640,000,000 | ||||||||||||||||||||||||||
| income tax (benefit) expense | -20,000,000 | 5,500,000 | -1,000,000 | -29,150,000 | -74,000,000 | -23,900,000 | -18,700,000 | 1,275,000 | -22,500,000 | ||||||||||||||||||
| loss per share: | |||||||||||||||||||||||||||
| basic | -0.29 | -2.22 | -0.11 | -0.1 | -0.193 | -0.21 | -0.43 | -0.12 | |||||||||||||||||||
| diluted | -0.29 | -2.22 | -0.11 | -0.1 | -0.193 | -0.21 | -0.43 | -0.12 | |||||||||||||||||||
| income tax expense | 5,000,000 | 14,300,000 | 13,300,000 | 18,600,000 | |||||||||||||||||||||||
| other–net, income | -40,425,000 | -114,900,000 | -47,900,000 | 13,500,000 | |||||||||||||||||||||||
| other–net, expense | 1,100,000 | 5,275,000 | 14,600,000 | 3,900,000 | 2,600,000 | ||||||||||||||||||||||
| asset impairments, restructuring and other special charges | 24,900,000 | 12,400,000 | |||||||||||||||||||||||||
| earnings per share: | |||||||||||||||||||||||||||
| basic and diluted | 0.16 | ||||||||||||||||||||||||||
| weighted-average shares outstanding: | |||||||||||||||||||||||||||
| basic and diluted | 365.6 |
We provide you with 20 years income statements for Elanco Animal Health stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Elanco Animal Health stock. Explore the full financial landscape of Elanco Animal Health stock with our expertly curated income statements.
The information provided in this report about Elanco Animal Health stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.